Compare studies and check their requirements with the research team.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including LimogesThis study is directly about Schizophrenia.
This study is looking at whether a digital support tool can help people with Schizophrenia spectrum disorder or affective disorder with psychotic symptoms or Mental and Behavioural Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
In GermanyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In PolandThis study is directly about Schizophrenia.
This study was terminated in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United KingdomThis study is directly about Schizophrenia.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
Multiple locations, including PazardzhikThis study is directly about Schizophrenia.
This study is looking at whether 1 can help people with Mental and Behavioural Disorders: Psychosis, Mental and Behavioural Disorders, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomThis study is directly about Schizophrenia.
This observational study is following people with Early phase psychosis, Mental and Behavioural Disorders, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
In SwitzerlandThis study is directly about Schizophrenia.
This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.